Clinical Cancer Research The Science of Cancer Health Disparities Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Milgraum, L. Z.
Right arrow Articles by Kuhajda, F. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Milgraum, L. Z.
Right arrow Articles by Kuhajda, F. P.

Clinical Cancer Research, Vol 3, Issue 11 2115-2120, Copyright © 1997 by American Association for Cancer Research


ARTICLES

Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma

LZ Milgraum, LA Witters, GR Pasternack and FP Kuhajda
Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.

Expression of high levels of fatty acid synthase (FAS), an important enzyme in fatty acid synthesis, has been identified in a wide variety of human carcinomas. In breast and prostate carcinoma, FAS expression appears to be associated with aggressive disease. Recent biochemical studies have demonstrated that FAS expression in cancer cells connotes activation of the entire fatty acid synthesis pathway leading to the production of palmitic acid. Here, we explore the immunohistochemical expression of FAS and human acetyl-CoA carboxylase (HACC), the rate-limiting enzyme in fatty acid synthesis, in breast cancer progression from histologically normal breast through the development of in situ duct and lobular carcinoma to infiltrating carcinoma. Both FAS and the Mr 275,000 isoform of HACC are expressed in a small subset of cells in normal breast lobules and terminal ducts. Upon development of either in situ duct or lobular carcinoma, FAS and both isoforms of HACC are expressed at higher levels and in a majority of the cells. These findings suggest that expression of the enzymes of fatty acid synthesis are frequently altered early in the progression of human breast carcinoma.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
S. Uddin, A. K. Siraj, M. Al-Rasheed, M. Ahmed, R. Bu, J. N. Myers, A. Al-Nuaim, S. Al-Sobhi, F. Al-Dayel, P. Bavi, et al.
Fatty Acid Synthase and AKT Pathway Signaling in a Subset of Papillary Thyroid Cancers
J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 4088 - 4097.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Ross, A. M. Najjar, M. Sankaranarayanapillai, W. P. Tong, K. Kaluarachchi, and S. M. Ronen
Fatty acid synthase inhibition results in a magnetic resonance-detectable drop in phosphocholine
Mol. Cancer Ther., August 1, 2008; 7(8): 2556 - 2565.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Furuta, S. K. Pai, R. Zhan, S. Bandyopadhyay, M. Watabe, Y.-Y. Mo, S. Hirota, S. Hosobe, T. Tsukada, K. Miura, et al.
Fatty Acid Synthase Gene Is Up-regulated by Hypoxia via Activation of Akt and Sterol Regulatory Element Binding Protein-1
Cancer Res., February 15, 2008; 68(4): 1003 - 1011.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Ma, R. Yan, X. Zu, J.-M. Cheng, K. Rao, D.-F. Liao, and D. Cao
Aldo-keto Reductase Family 1 B10 Affects Fatty Acid Synthesis by Regulating the Stability of Acetyl-CoA Carboxylase-{alpha} in Breast Cancer Cells
J. Biol. Chem., February 8, 2008; 283(6): 3418 - 3423.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. H. Suh, E.-Y. Gong, J. B. Kim, I.-K. Lee, H.-S. Choi, and K. Lee
Sterol Regulatory Element-Binding Protein-1c Represses the Transactivation of Androgen Receptor and Androgen-Dependent Growth of Prostatic Cells
Mol. Cancer Res., February 1, 2008; 6(2): 314 - 324.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Yoon, M.-Y. Lee, S. W. Park, J.-S. Moon, Y.-K. Koh, Y.-H. Ahn, B.-W. Park, and K.-S. Kim
Up-regulation of Acetyl-CoA Carboxylase {alpha} and Fatty Acid Synthase by Human Epidermal Growth Factor Receptor 2 at the Translational Level in Breast Cancer Cells
J. Biol. Chem., September 7, 2007; 282(36): 26122 - 26131.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Beckers, S. Organe, L. Timmermans, K. Scheys, A. Peeters, K. Brusselmans, G. Verhoeven, and J. V. Swinnen
Chemical Inhibition of Acetyl-CoA Carboxylase Induces Growth Arrest and Cytotoxicity Selectively in Cancer Cells
Cancer Res., September 1, 2007; 67(17): 8180 - 8187.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
J. G. Pan and T. W. Mak
Metabolic Targeting as an Anticancer Strategy: Dawn of a New Era?
Sci. Signal., April 10, 2007; 2007(381): pe14 - pe14.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Zhou, W. F. Han, L. E. Landree, J. N. Thupari, M. L. Pinn, T. Bililign, E. K. Kim, A. Vadlamudi, S. M. Medghalchi, R. El Meskini, et al.
Fatty Acid Synthase Inhibition Activates AMP-Activated Protein Kinase in SKOV3 Human Ovarian Cancer Cells
Cancer Res., April 1, 2007; 67(7): 2964 - 2971.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
O. M. Sinilnikova, J. D. McKay, S. V. Tavtigian, F. Canzian, D. DeSilva, C. Biessy, S. Monnier, L. Dossus, C. Boillot, L. Gioia, et al.
Haplotype-Based Analysis of Common Variation in the Acetyl-CoA Carboxylase {alpha} Gene and Breast Cancer Risk: A Case-Control Study Nested within the European Prospective Investigation into Cancer and Nutrition
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 409 - 415.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. L. Little, F. B. Wheeler, D. R. Fels, C. Koumenis, and S. J. Kridel
Inhibition of Fatty Acid Synthase Induces Endoplasmic Reticulum Stress in Tumor Cells
Cancer Res., February 1, 2007; 67(3): 1262 - 1269.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Lupu and J. A. Menendez
Targeting Fatty Acid Synthase in Breast and Endometrial Cancer: An Alternative to Selective Estrogen Receptor Modulators?
Endocrinology, September 1, 2006; 147(9): 4056 - 4066.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Bandyopadhyay, R. Zhan, Y. Wang, S. K. Pai, S. Hirota, S. Hosobe, Y. Takano, K. Saito, E. Furuta, M. Iiizumi, et al.
Mechanism of Apoptosis Induced by the Inhibition of Fatty Acid Synthase in Breast Cancer Cells
Cancer Res., June 1, 2006; 66(11): 5934 - 5940.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Chajes, M. Cambot, K. Moreau, G. M. Lenoir, and V. Joulin
Acetyl-CoA Carboxylase {alpha} Is Essential to Breast Cancer Cell Survival.
Cancer Res., May 15, 2006; 66(10): 5287 - 5294.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
X. Zhang and F. L. Kiechle
Fatty Acid Synthase and its mRNA Concentrations Are Decreased at Different Times Following Hoechst 33342-induced Apoptosis in BC3H-1 Myocytes.
Ann. Clin. Lab. Sci., March 1, 2006; 36(2): 185 - 193.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Moreau, E. Dizin, H. Ray, C. Luquain, E. Lefai, F. Foufelle, M. Billaud, G. M. Lenoir, and N. D. Venezia
BRCA1 Affects Lipid Synthesis through Its Interaction with Acetyl-CoA Carboxylase
J. Biol. Chem., February 10, 2006; 281(6): 3172 - 3181.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Y. Chang, J. Wang, X. Lu, D. P. Thewke, and R. J. Mason
KGF induces lipogenic genes through a PI3K and JNK/SREBP-1 pathway in H292 cells
J. Lipid Res., December 1, 2005; 46(12): 2624 - 2635.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
D. Zhang, L. K. Tai, L. L. Wong, L.-L. Chiu, S. K. Sethi, and E. S. C. Koay
Proteomic Study Reveals That Proteins Involved in Metabolic and Detoxification Pathways Are Highly Expressed in HER-2/neu-positive Breast Cancer
Mol. Cell. Proteomics, November 1, 2005; 4(11): 1686 - 1696.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Brusselmans, E. De Schrijver, G. Verhoeven, and J. V. Swinnen
RNA Interference-Mediated Silencing of the Acetyl-CoA-Carboxylase-{alpha} Gene Induces Growth Inhibition and Apoptosis of Prostate Cancer Cells
Cancer Res., August 1, 2005; 65(15): 6719 - 6725.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J. A. Menendez, L. Vellon, and R. Lupu
Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene
Ann. Onc., August 1, 2005; 16(8): 1253 - 1267.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
O. M. Sinilnikova, S. M. Ginolhac, C. Magnard, M. Leone, O. Anczukow, D. Hughes, K. Moreau, D. Thompson, C. Coutanson, J. Hall, et al.
Acetyl-CoA carboxylase {alpha} gene and breast cancer susceptibility
Carcinogenesis, December 1, 2004; 25(12): 2417 - 2424.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. A. Menendez, L. Vellon, I. Mehmi, B. P. Oza, S. Ropero, R. Colomer, and R. Lupu
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells
PNAS, July 20, 2004; 101(29): 10715 - 10720.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. M. Knowles, F. Axelrod, C. D. Browne, and J. W. Smith
A Fatty Acid Synthase Blockade Induces Tumor Cell-cycle Arrest by Down-regulating Skp2
J. Biol. Chem., July 16, 2004; 279(29): 30540 - 30545.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Zhou, P. J. Simpson, J. M. McFadden, C. A. Townsend, S. M. Medghalchi, A. Vadlamudi, M. L. Pinn, G. V. Ronnett, and F. P. Kuhajda
Fatty Acid Synthase Inhibition Triggers Apoptosis during S Phase in Human Cancer Cells
Cancer Res., November 1, 2003; 63(21): 7330 - 7337.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
F. D. Camassei, R. Cozza, A. Acquaviva, A. Jenkner, L. Rava, R. Gareri, A. Donfrancesco, C. Bosman, P. Vadala, T. Hadjistilianou, et al.
Expression of the Lipogenic Enzyme Fatty Acid Synthase (FAS) in Retinoblastoma and Its Correlation with Tumor Aggressiveness
Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2399 - 2403.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Takahiro, K. Shinichi, and S. Toshimitsu
Expression of Fatty Acid Synthase as a Prognostic Indicator in Soft Tissue Sarcomas
Clin. Cancer Res., June 1, 2003; 9(6): 2204 - 2212.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Kumar-Sinha, K. W. Ignatoski, M. E. Lippman, S. P. Ethier, and A. M. Chinnaiyan
Transcriptome Analysis of HER2 Reveals a Molecular Connection to Fatty Acid Synthesis
Cancer Res., January 1, 2003; 63(1): 132 - 139.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Van de Sande, E. De Schrijver, W. Heyns, G. Verhoeven, and J. V. Swinnen
Role of the Phosphatidylinositol 3'-Kinase/PTEN/Akt Kinase Pathway in the Overexpression of Fatty Acid Synthase in LNCaP Prostate Cancer Cells
Cancer Res., February 1, 2002; 62(3): 642 - 646.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. A. Porter, I. E. Krop, S. Nasser, D. Sgroi, C. M. Kaelin, J. R. Marks, G. Riggins, and K. Polyak
A SAGE (Serial Analysis of Gene Expression) View of Breast Tumor Progression
Cancer Res., August 1, 2001; 61(15): 5697 - 5702.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
T. Kusakabe, M. Maeda, N. Hoshi, T. Sugino, K. Watanabe, T. Fukuda, and T. Suzuki
Fatty Acid Synthase Is Expressed Mainly in Adult Hormone-sensitive Cells or Cells with High Lipid Metabolism and in Proliferating Fetal Cells
J. Histochem. Cytochem., May 1, 2000; 48(5): 613 - 622.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
E. S. Pizer, J. Thupari, W. F. Han, M. L. Pinn, F. J. Chrest, G. L. Frehywot, C. A. Townsend, and F. P. Kuhajda
Malonyl-Coenzyme-A Is a Potential Mediator of Cytotoxicity Induced by Fatty-Acid Synthase Inhibition in Human Breast Cancer Cells and Xenografts
Cancer Res., January 1, 2000; 60(2): 213 - 218.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. Lacasa, X. Le Liepvre, P. Ferre, and I. Dugail
Progesterone Stimulates Adipocyte Determination and Differentiation 1/Sterol Regulatory Element-binding Protein 1c Gene Expression. POTENTIAL MECHANISM FOR THE LIPOGENIC EFFECT OF PROGESTERONE IN ADIPOSE TISSUE
J. Biol. Chem., April 6, 2001; 276(15): 11512 - 11516.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. P. Kuhajda, E. S. Pizer, J. N. Li, N. S. Mani, G. L. Frehywot, and C. A. Townsend
Synthesis and antitumor activity of an inhibitor of fatty acid synthase
PNAS, March 28, 2000; 97(7): 3450 - 3454.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.